195 related articles for article (PubMed ID: 3974771)
1. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
Mudde AH; Roodvoets AP; Van Groningen K
Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
[No Abstract] [Full Text] [Related]
2. [Treatment of dialysis encephalopathy with deferoxamine].
Starkstein S; Berthier M; Nogués M; Leiguarda R
Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
[No Abstract] [Full Text] [Related]
3. Role of desferrioxamine in the treatment of dialysis encephalopathy.
Ackrill P; Ralston AJ; Day JP
Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
[No Abstract] [Full Text] [Related]
4. Aluminum bone disease. (A case study).
Coleman S
J Nephrol Nurs; 1985; 2(3):125-6. PubMed ID: 3848476
[No Abstract] [Full Text] [Related]
5. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
Milne FJ; Sharf B; Bell P; Meyers AM
Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
[TBL] [Abstract][Full Text] [Related]
6. Changes in bone histology after treatment with desferrioxamine.
Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
[No Abstract] [Full Text] [Related]
7. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
Lillevang ST; Pedersen FB
Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
[No Abstract] [Full Text] [Related]
8. Therapy of aluminium overload (II).
Ackrill P; Day JP
Contrib Nephrol; 1984; 38():78-80. PubMed ID: 6713902
[No Abstract] [Full Text] [Related]
9. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D
Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
[TBL] [Abstract][Full Text] [Related]
10. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
[No Abstract] [Full Text] [Related]
11. Epidemiology of aluminium toxicity in a 'low incidence' area.
Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
[No Abstract] [Full Text] [Related]
12. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
Espinoza O; Gehrung E; Roessler E; Katz E; Pérez A; Delmastro J
Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972
[No Abstract] [Full Text] [Related]
13. Recognition and management of aluminum intoxication in children.
Tsuru N; Williams JL; Chan JC
Int J Pediatr Nephrol; 1987; 8(3):177-86. PubMed ID: 3323095
[TBL] [Abstract][Full Text] [Related]
14. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
Charhon SA; Chavassieux P; Chapuy MC; Accominotti M; Traeger J; Meunier PJ
Presse Med; 1986 Jan; 15(2):55-9. PubMed ID: 2935857
[TBL] [Abstract][Full Text] [Related]
15. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
Nielsen LP; Heaf JG
Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
[No Abstract] [Full Text] [Related]
16. Therapy of aluminum overload (I).
Pierides AM; Myli MP
Contrib Nephrol; 1984; 38():65-77. PubMed ID: 6425013
[No Abstract] [Full Text] [Related]
17. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
O'Brien AA; McParland C; Keogh JA
Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
[TBL] [Abstract][Full Text] [Related]
18. Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
Arze RS; Parkinson IS; Cartlidge NE; Britton P; Ward MK
Lancet; 1981 Nov; 2(8255):1116. PubMed ID: 6118567
[No Abstract] [Full Text] [Related]
19. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
[No Abstract] [Full Text] [Related]
20. [Aluminum osteopathy--experience with therapy].
Sulková S
Vnitr Lek; 1993 May; 39(5):459-63. PubMed ID: 8351877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
